Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia-Reference-Cited by-同舟云学术

Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia

Published:2020-11-18 Issue:4 Volume:116 Page:675-682
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Frei Nicola F.,Khoshiwal Amir M.,Konte Kadere,Bossart Emily A.,Stebbins Katelyn,Zhang Yi,Pouw Roos E.,ten Kate Fiebo J.W.,Seldenrijk Kees A.,Meijer Sybren L.,Critchley-Thorne Rebecca J.,Bergman Jacques J.G.H.M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. American Gastroenterological Association medical position statement on the management of Barrett's esophagus;Spechler;Gastroenterology,2011

2. ACG clinical guideline: Diagnosis and management of Barrett's esophagus;Shaheen;Am J Gastroenterol,2015

3. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation;Montgomery;Hum Pathol,2001

4. Discordance among pathologists in the United States and Europe in diagnosis of low-grade dysplasia for patients with Barrett's esophagus;Vennalaganti;Gastroenterology,2017

5. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement;Weusten;Endoscopy,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Tissue Systems Pathology Test Objectively Risk-Stratifies Patients With Barrett’s Esophagus;Journal of Clinical Gastroenterology;2024-07-02

2. The Aberrant Expression of Biomarkers and Risk Prediction for Neoplastic Changes in Barrett’s Esophagus–Dysplasia;Cancers;2024-06-28

3. Narrowing the Discrepancy in Interobserver Variability With Barrett’s Esophagus With Low-Grade Dysplasia: Will Biomarkers or Risk Testing Help?;Foregut: The Journal of the American Foregut Society;2024-05-21

4. TSP-9: A Barrett’s Esophagus Biomarker Better Than Pathologists?;Gastroenterology;2023-11

5. The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia;Gastroenterology;2023-11